Define Euglycemic DKA and its clinical significance Understand diagnostic criteria and why it can be missed. Explain epidemiology and risk factors for Euglycemic DKA Including SGLT2 inhibitor use and other precipitating factors. Describe pathogenesis and pathophysiology of Euglycemic DKA Mechanisms involving insulin, glucagon, and carbohydrate deficit. Identify clinical presentation and investigations for Euglycemic DKA Labs, imaging, and differential diagnosis. Outline treatment principles for Euglycemic DKA Fluid therapy, insulin therapy, potassium replacement, and discontinuation of SGLT2 inhibitors. Discuss DKA in special populations Pregnancy: risks, pathophysiology, maternal and fetal complications, multidisciplinary care. Extremes of age: pediatric/young adults (risk of cerebral edema) and elderly (atypical presentation, comorbidities). Heart failure: fluid management challenges and monitoring strategies. Kidney disease (AKI, CKD, ESRD): tailored fluid therapy, insulin dosing, dialysis considerations. Highlight prevention strategies and multidisciplinary approach Education, monitoring, and individualized care plans.